Literature DB >> 31015391

Clinical and Imaging Features of a Ruptured Epidermal Inclusion Cyst in the Subareolar Area: A Case Report.

Suk Jung Kim1, Woo Gyeong Kim2.   

Abstract

BACKGROUND Epidermal inclusion cysts rarely develop in the breast. The cysts that do develop within the breast typically present as cutaneous or subcutaneous cysts. They more rarely present in a subareolar location or in a ruptured state. Thus far, 5 cases of ruptured epidermal inclusion cysts in subareolar locations have been reported in the English literature. Furthermore, clinical presentation of nipple discharge is rare in epidermal inclusion cysts of the breast; only 4 such cases has been reported. CASE REPORT A 58-year-old female presented with a 1-month history of bloody discharge from her left nipple. Mammography showed focal asymmetry in the left subareolar region; sonography showed a left subareolar mass with irregular shape, indistinct margin, heterogeneous echogenicity, and posterior enhancement. The mass was surgically excised; a pathological diagnosis of ruptured epidermal inclusion cyst with foreign body reaction and abscess formation was established. In this case, the clinical presentation of bloody nipple discharge was peculiar; furthermore, mammographic and sonographic features were indistinguishable from breast malignancy or typical breast abscess. CONCLUSIONS A ruptured epidermal inclusion cyst can present in an unusual subareolar location, combined with bloody nipple discharge; importantly, this can radiologically resemble breast malignancy.

Entities:  

Mesh:

Year:  2019        PMID: 31015391      PMCID: PMC6501737          DOI: 10.12659/AJCR.914412

Source DB:  PubMed          Journal:  Am J Case Rep        ISSN: 1941-5923


Background

Epidermal inclusion cyst is a benign cutaneous or subcutaneous lesion lined by stratified squamous epithelium and filled with keratin debris [1]. This type of cyst develops as a result of the proliferation and implantation of epidermal elements within a circumscribed space in the dermis [2]. Its occurrence in the breast is rare; when it does affect the breast, this type of cyst is primarily localized in the skin layer and periareolar region [2]. There have been 15 cases reported in which an epidermal inclusion cyst occurred in the sub- or peri-areolar area [3]. This report describes a ruptured epidermal inclusion cyst of the breast with an unusual location within the subareolar area, as well as its unusual clinical presentation with bloody nipple discharge. Furthermore, this report describes the mammographic and sonographic features of this cyst, which mimicked those of breast malignancies.

Case Report

A 58-year-old female presented with left bloody nipple discharge that had occurred for 1 month. Her medical history included medications for diabetes mellitus and hypertension. She had no family history of breast cancer. There was no associated history of trauma. Upon clinical examination, erythematous change was noted in the skin of the left nipple-areolar complex. Mammography showed left subareolar focal asymmetry (Figure 1A, 1B). No microcalcifications were observed alongside the focal asymmetry on mammography examination. Sonography showed a 1.8-cm subareolar mass with irregular shape, indistinct margin, heterogeneous echogenicity, and posterior enhancement (Figure 2A, 2B). Color Doppler sonogram revealed increased vascularity within the mass and adjacent tissue (Figure 2C). The clinical feature of the bloody nipple discharge, mammographic feature of focal asymmetry in the subareolar region, and sonographic feature of an irregular indistinct subareolar mass with increased vascularity indicated a subareolar abscess or breast malignancies; based on these findings, the cyst was classified as category 4b according to the Breast Imaging Reporting and Data System (BI-RADS) classification. The mass was surgically excised, which led to a pathological diagnosis of ruptured epidermal inclusion cyst with foreign body reaction and abscess formation (Figure 3A, 3B).
Figure 1.

(A) Craniocaudal and (B) mediolateral mammograms show a focal asymmetry in the left subareolar area. No microcalcifications are associated with the focal asymmetry.

Figure 2.

(A) Transverse and (B) longitudinal gray-scale sonograms show an irregular indistinct heterogeneous hypoechoic mass in the left subareolar area. Note the posterior enhancement deep to the mass. (C) Color Doppler sonogram shows a degree of increased vascularity within the mass and adjacent tissue.

Figure 3.

Microscopic findings of the epidermal inclusion cyst. (A) A cystic lesion is lined by benign stratified squamous epithelium filled with abundant lamellated basket weave keratin (hematoxylin and eosin staining 40×). (B) Adjacent tissue exhibits inflammatory infiltrate cells with clusters of multinucleated giant cells, indicative of a foreign body reaction (hematoxylin and eosin staining 200×).

Microscopically, the cystic lesion was lined with benign stratified squamous epithelium filled with abundant lamellated basket-weave keratin. Adjacent tissue exhibited inflammatory infiltrate cells with clusters of multinucleated giant cells; this was indicative of a foreign body reaction.

Discussion

Epidermal inclusion cysts are formed by inclusion of keratinizing squamous epithelium within the dermis [4]. Epidermal inclusion cysts have also been described by other terms, such as follicular infundibular cysts, epidermal cysts, and epidermoid cysts [5]. These cysts are commonly cutaneous or subcutaneous, and present in hairy body areas such as scalp, neck, and trunk [5-7]. They rarely occur in the breast; Menville et al. reported the first case of epidermal inclusion cyst of the breast in 1900 [2,8]. Paliotta et al. identified a total of 91 patients affected by epidermal inclusion cysts of the breast through a search of the literature in 2014 [2], and thereafter, sporadic case reports of epidermal inclusion cysts have been published until recently [7,9-15]. Epidermal inclusion cysts of the breast typically develop during the fifth decade of life [2], and are usually located in the skin; however, they can develop in unusual locations, such as cutaneously on the nipple or areola or intra-parenchymally in the subor peri-areolar regions. Through a search of the literature, we identified a total of 21 cases where epidermal inclusion cysts developed in these unusual locations; 15 in sub- or peri-areolar region [1,3,5,12,16-19], 4 on the nipple [11,13,14,20], and 2 on the areola [10,11] (Table 1). Furthermore, we found presentations of nipple discharge in a total of 4 cases in the literature; 3 cases in sub- or peri-areolar regions [3,12,16] and 1 case on the nipple [14]. The nature of nipple discharge in these cases was not specifically described; however, it was briefly mentioned as non-bloody in 1 case [12], purulent in 1 case [16], yellowish in 1 case [3], and infected in 1 case (Staphylococcus aureus isolated from discharge culture) [14]. Similar to the current case, all these previous cases showing nipple discharge were associated with complications such as rupture [3,12,16], infection [14], inflammation [3], or abscess [16]. To our knowledge, the current case is the fifth presentation of nipple discharge (and the first one presenting as a bloody nature) with an epidermal inclusion cyst of the breast and the 16th report of an epidermal inclusion cyst with sub- or peri-areolar location in the breast.
Table 1.

Previous reports of epidermal inclusion cysts involving the nipple-areola or sub- or peri-areolar region.

Case no.AuthorsPublished yearAgeSexLocationSizeDurationClinical presentationsNipple dischargeTrauma historyComplication at presentationSonographic features
1Amrani et al. [11]20189 monthsMAreola1 cmSince birthWhite, dome-shaped, soft, fluctuant, non-tenderAbsentAbsentAbsentNot available
2Amrani et al. [11]20183 monthsMNipple2 cmSince birthWhite, dome-shaped, freely movable, nontender, smooth surfacedAbsentAbsentAbsentNot available
3Ben Naftali et al. [10]201844 yearsFAreola4 cmA few monthsA solid polypoid irregular massAbsentAbsentPresent (chronic inflammation)A mass with local edema and an axillary lymph node with a thick cortex (BIRADS IVa)
4Martin et al. [12]201442 yearsFSubareolar3.75 cmNot availableNipple dischargePresent (non bloody)Present (reduction mammoplasty)Present (ruptureA solid, well circumscribed ovoid mass
5Marchesi et al. [13]201439 yearsMNipple1.3 cm5 monthsAn enlarging cutaneous lesion (exophytic, polypoid protuberance)AbsentAbsentAbsentCystic lesion
6Dilek et al. [14]201427 yearsFNipple0.4 cm2 yearsPainful, white, soft, immobile, firm, smooth of staphylosurfacedPresent (isolation coccus from the discharge)AbsentPresent (infection, staphylococcus isolated from nipple discharge)Well circumscribed, central hyperechoic mass
7Jain et al. [20]201215 monthsFNipple0.8 cm2 monthsWell circumscribed, pearly white, dome-shaped, soft, non-tenderAbsentPresent (squeezing the breast during neonatal period to express the witch’s milk)AbsentNot available
8Singh et al. [16]201260 yearsFPeri-areolar1 cm15 daysFirm, mobile non-tender, partially adhered to the skinAbsentAbsentAbsentNot available
9Singh et al. [16]201230 yearsFPeri-areolar1 cm6–7 yearsFirm, mobile, mildly tender, partially adhered to the skinAbsentAbsentAbsentNot available
10Singh et al. [16]201238 yearsFPeri-areolar1.5 cm2 monthsFirm, mobile, non-tenderAbsentAbsentAbsentNot available
11Singh et al. [16]201232 yearsFPeri-areolar1.5 cm2 monthsFirm, partially mobile, tender, pus-discharging sinusPresent (purulent)AbsentPresent (rupture, infection)Not available
12Singh et al. [16]201232 yearsMPeri-areolar1 cm1 monthsFirm, mobile, non-tender, partially adhered to the skinAbsentAbsentAbsentNot available
13Singh et al. [16]201225 yearsMPeri-areolar1 cm2 monthsFirm. mobileAbsentAbsentAbsentNot available
14Lee et al. [5]201247 yearsFSubareolar> 8 cm6 monthsFirm, well circumscribed, attached to the skinAbsentAbsentPresent (microrupture)Solid, hypoechoic mass with heterogeneous echoes and well demarcated border
15Debanath et al. [17]201269 yearsFSubareolar8.5 cm3 monthsPainful, firm, nipple retractionAbsentPresent (traffic accident)Present (inflammation)Solid mass extending into the ductal system (highly suspicious for malignancy)
16Whang et al. [3]200750 yearsFSubareolar1.8 cm1 weekSubareolar pain, palpable massAbsentNot availablePresent (rupture)Ill-defined, heterogeneous, hypoechoic, irregular shaped mass
17Whang et al. [3]200744 yearsFSubareolar2.2 cmSeveral monthsPeriareolar painPresent (yellowish)Not availablePresent (rupture, inflammation)Ill-defined mass with irregular shape, heterogeneous echogenicity, posterior enhancement
18Kwak et al. [1]200423 yearsFSubareolar4.4 cm4 yearsPainful, palpable massAbsentAbsentAbsentWell-defined heterogeneous echoic mass, no blood flow within the mass
19Stephenson et al. [18]198752 yearsFSubareolar0.8 cmNot availableUnremarkableAbsentAbsentPresent (Paget’s disease)Not available
20Gerlock [19]197441 yearsFSubareolar2.5 cm2 yearsPainful, Hard, sharply marginatedAbsentPresent (needle biopsy)AbsentNot available
21Gerlock [19]197462 yearsFSubareolar1.5 cm5 yearsPainful, firmly affected to the skinAbsentPresent (needle biopsy)AbsentNot available
22Current201958 yearsFSubareolar1.8 cm1 monthBloody nipple dischargePresent (bloody)AbsentPresent (rupture, abscess)Irregular, indistinct, heterogeneous, posterior enhancement

M – Male; F – Female.

When epidermal inclusion cysts affect the breast, their clinical appearance commonly comprises that of palpable lumps (79%); less commonly, symptoms include local discomfort (67%), inflammation (33%), spontaneous rupture (12%), and ulceration (4%) [2,21]. Actual pathogenesis in the formation of epidermal inclusion cysts is not completely understood. However, several etiologies may be involved [1,5,22]. First, they are assumed to be congenital in the majority of cases [2,5]. Second, they can result from obstructed hair follicles [1,2,22]. Third, they can be derived from implanted epidermal fragments within breast tissue due to trauma such as reduction mammoplasty or needle biopsy [2,6,19,23,24]. Fourth, inflamed pilosebaceous structures can result in a cystic reaction in the dermis [2,5]. Fifth, they can result from a squamous metaplastic transformation of normal columnar cells of the breast within an ectatic duct in fibrocystic disease or fibroadenoma [2,25,26]. Among the 15 previously reported cases of epidermal inclusion cyst in sub- or peri-areolar regions, 4 cases were associated with trauma [12,19]; 1 case with reduction mammoplasty [12], 1 case with a traffic accident [17], and 2 cases with needle biopsy [19]. Furthermore, 6 cases were presumed to have resulted from obstruction of a hair follicle [16]. However, possible mechanisms were not proposed in the remaining 5 cases [1,3,5,18]. Sonographic presentation of epidermal inclusion cysts of breast is generally that of a circumscribed mass with complex cystic and solid or heterogeneous internal echogenicity, as well as posterior enhancement [2,21]. A characteristic “onion-ring” sign, along with alternating concentric hyperechoic and hypoechoic rings corresponding to lamellated keratin have been reported in some epidermal inclusion cysts [4]. Instead of an “onion-ring” sign, a “tram-track” appearance consisting of multiple parallel alternating echogenic and hypoechoic lines was also reported in 1 case [15]. Among the previous 15 cases of epidermal inclusion cysts in the sub- or peri-areolar regions, sonographic features were described in 6 cases [1,3,5,12,17]. Similar to the current case, 3 cases demonstrated suspicious sonographic features [3,17] that were indistinguishable from breast malignancies, whereas the remaining 3 cases demonstrated usual sonographic features favoring benign lesion [1,5,12]. Mammographic presentation of epithelial inclusion cysts of the breast usually includes a circumscribed iso- or hyperdense mass [2,21] and can sometimes be accompanied by microcalcifications [21]. Magnetic resonance imaging features were reported in a few cases, which were circumscribed masses with a fluid-like signal of a variable low-signal component on T2-weighted images and peripheral rim enhancement [2,5,6,9] or no enhancement [22] on contrast-enhanced images. Epidermal inclusion cysts of the breast are associated with several complications such as spontaneous rupture, inflammation, and abscess formation [1]. In the case of rupture, the released keratin from the cyst might act as an irritant resulting in a foreign body reaction, granulomatous reaction, and abscess formation [5]. Furthermore, the transformation of epidermal inclusion cyst of the breast to squamous cell carcinoma has been reported; the reported incidence greatly varies from 0.045% to 19% [5]. Through a literature search, Paliotta et al. determined that the overall rate was 12% [2]. The rate of malignant transformation of epidermal inclusion cysts in the breast appears to be more frequent compared to that in other body parts, possibly due to the pathogenesis of squamous metaplasia affecting the mammary duct epithelium [2]. A significant association has been observed between tumor size and malignancy transformation [2]. Specifically, when larger than 5 cm in diameter, epidermal inclusion cysts are classified as giant, which are rare and more likely to develop complications such as malignant transformation [7]. Paget’ s disease involving a subareolar epidermal inclusion cyst also has been reported in 1 case [18]. Because of the potential for malignant transformation, surgical excision is recommended, especially when the cyst is large (≥2 cm) and palpable, or when it causes the patient discomfort [2]. However, asymptomatic small sized lesions might not require treatment [5].

Conclusions

This report describes a ruptured epidermal inclusion cyst that was observed in an unusual location (subareolar area) and had an unusual clinical presentation (bloody nipple discharge), which was radiologically indistinguishable from malignancy. Awareness of this unusual manifestation of epidermal inclusion cyst can be useful when assessing subareolar breast pathology.
  1 in total

1.  An epidermal cyst in the areola.

Authors:  Toshiyuki Yamaguchi
Journal:  Clin Case Rep       Date:  2022-07-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.